[HTML][HTML] Helicobacter pylori Antibiotic Resistance: Molecular Basis and Diagnostic Methods

I Medakina, L Tsapkova, V Polyakova… - International Journal of …, 2023 - mdpi.com
Helicobacter pylori is one of the most common cause of human infections. Infected patients
develop chronic active gastritis in all cases, which can lead to peptic ulcer, atrophic gastritis …

Current and Future Perspectives on the Management of Helicobacter pylori: A Narrative Review

C Deane, O Kelly, C O'Morain - Antibiotics, 2024 - mdpi.com
The prevalence of Helicobacter pylori (H. pylori), a pathogen, has decreased globally in the
last decade. To date, the management of H. pylori has focused on a reactive approach …

A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms

F Ishibashi, K Okusa, Y Tokai, T Hirasawa, T Kawakami… - Gastric Cancer, 2024 - Springer
Background The effectiveness of esophagogastroduodenoscopy (EGD) screening in cohorts
with low Helicobacter pylori prevalence is unknown. This study aimed to develop an …

[HTML][HTML] Genetic Markers of Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Moscow, Russia

N Bodunova, L Tsapkova, V Polyakova… - Current Issues in …, 2024 - mdpi.com
The Maastricht VI/Florence consensus recommends, as one of the measures to enhance the
efficacy of Helicobacter pylori infection eradication, a personalized treatment approach …

Culture‐based susceptibility‐guided tailored versus empirical concomitant therapy as first‐line Helicobacter pylori treatment: A randomized clinical trial

JH Lee, BH Min, EJ Gong, JY Kim… - United European …, 2024 - Wiley Online Library
Background With the increasing resistance to antimicrobial agents, susceptibility‐guided
tailored therapy has been emerging as an ideal strategy for Helicobacter pylori treatment …